Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA)

Salazar, O.M; Sandhu, T; da Motta, N.W; Escutia, M.A; Lanzos-Gonzales, E; Mouelle-Sone, A; Moscol, A; Zaharia, M; Zaman, S

doi:10.1016/S1278-3218(02)00179-8

Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA)

Auteurs : Salazar OM, Sandhu T, da Motta NW, Escutia MA, Lanzos-Gonzales E, Mouelle-Sone A, Moscol A, Zaharia M, Zaman SDate 2002, Vol 6, Num 4, pp 267-268Revue : Cancer radiothérapie : journal de la Société française de radiothérapie oncologiqueType de publication : Compte rendu d'ouvrage; DOI : 10.1016/S1278-3218(02)00179-8

Analyse d'essai clinique

Aucun résumé disponible

Source : Elsevier-Masson

Accès à l'article

Accès restreint

Accès à distance aux ressources électroniques :

Exporter

Citer cet article

Salazar OM, Sandhu T, da Motta NW, Escutia MA, Lanzos-Gonzales E, Mouelle-Sone A, Moscol A, Zaharia M, Zaman S. Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (IAEA). Cancer Radiother. 2002;6(4):267-268.

Indicateur SJR (2002) : 0.143